Wealth Management Insights

For much of the past half century, the social contract underpinning pharmaceutical innovation was clear. New drugs delivered longer lives, fewer hospitalisations and, in some cases, cures. In return, societies accepted steadily rising healthcare spending. That contract held as long as innovation visibly transformed outcomes. It is now being renegotiated.